Showing results (201-210 of 219) with videos related to

Sort By:
Pageof 22
Clinical Genitourinary Cancer|February 4, 2025
Enzalutamide and Docetaxel in Combination With Androgen Deprivation for Men With Metastatic Hormone-Sensitive Prostate Cancer: ENZADA, a Phase II TrialEarle F Burgess, Claud M Grigg, Danielle Boselli, et al.
JCO Precision Oncology|February 8, 2023
Olaparib in Patients With Metastatic Prostate Cancer With <i>BRCA1</i>/<i>2</i> Mutation: Results From the TAPUR StudyEddy S Yang, Susan Halabi, Michael Rothe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trialA O Siefker-Radtke, N Matsubara, S H Park, et al.
Implementation Science : IS|March 8, 2017
Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trialShannon Wiltsey Stirman, Erin P Finley, Norman Shields, et al.
Clinical Genitourinary Cancer|May 2, 2024
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With ChemotherapyLandon C Brown, Myra Robinson, Michael McCormack, et al.
Vaccine: X|April 6, 2023
COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patientsZainab Shahid, Alicia L Patrick, Michelle L Wallander, et al.
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Translational Andrology and Urology|August 25, 2021
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patientsJ Alexa Sanders, Connor Frasier, Justin T Matulay, et al.
Clinical Genitourinary Cancer|June 7, 2025
Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Exploratory Analysis of the Asian Subpopulation in the THOR Phase 3 StudyNobuaki Matsubara, Yohann Loriot, Earle F Burgess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Phase I study of docetaxel in combination with the P-glycoprotein inhibitor, zosuquidar, in resistant malignanciesPaula M Fracasso, Lori J Goldstein, Dinesh P de Alwis, et al.
Pageof 22